Bridgeway Capital Management’s China Pharma Holdings CPHI Stock Holding History

Bridgeway Capital Management’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-290	Closed	-$4.95K	–	1377
2023 Q2	$4.95K	Hold	290	–	–	﹤0.01%	1375
2023 Q1	$5.66K	Hold	290	–	–	﹤0.01%	1375
2022 Q4	$13.9K	Hold	290	–	–	﹤0.01%	1354
2022 Q3	$19K	Sell	290 -100	-26%	-$9.86K	﹤0.01%	1394
2022 Q2	$42K	Hold	390	–	–	﹤0.01%	1291
2022 Q1	$76K	Hold	390	–	–	﹤0.01%	1275
2021 Q4	$94K	Hold	390	–	–	﹤0.01%	1224
2021 Q3	$109K	Hold	390	–	–	﹤0.01%	1247
2021 Q2	$141K	Sell	390 -80	-17%	-$28.8K	﹤0.01%	1291
2021 Q1	$197K	Hold	470	–	–	﹤0.01%	1286
2020 Q4	$105K	Hold	470	–	–	﹤0.01%	1269
2020 Q3	$86K	Hold	470	–	–	﹤0.01%	1266
2020 Q2	$157K	Buy	+470	New	+$116K	﹤0.01%	1182

Other funds holding CPHI

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FCT

First Community Trust Dubuque, Iowa $221M AUM 48.25% 1-Year Est. Return

Bridgeway Capital Management's CPHI Position: Q3 2023 in Review

Bridgeway Capital Management sold out of China Pharma Holdings (CPHI) in Q3 2023, closing a stake of 290 shares — an estimated $4.95K sold.

Bridgeway Capital Management first reported a position in CPHI in Q2 2020 and held it in 13 quarters. The position peaked at $197K in Q1 2021. 5 funds tracked by Wall St. Rank hold CPHI as of Q3 2023.

Bridgeway Capital Management reported no remaining China Pharma Holdings position as of Q3 2023 after selling out during the quarter.
Bridgeway Capital Management sold 290 China Pharma Holdings shares in Q3 2023, an estimated $4.95K.
Bridgeway Capital Management first reported a position in China Pharma Holdings in Q2 2020 and held it in 13 quarters.
Bridgeway Capital Management's China Pharma Holdings position peaked at $197K in Q1 2021.
5 funds tracked by Wall St. Rank held China Pharma Holdings as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.